Names and pronunciation
(gil′teh-rih′tih-nib) Xospata
PDF page 626
Drug reference
(gil′teh-rih′tih-nib) Xospata
PDF page 626
Func. class.: Antineoplastic
PDF page 626
Chem. class.: Kinase inhibitor
PDF page 626
USES: Acute myeloid leukemia- relapsed or the treatment of relapsed or refractory FLT3 mutation–positive AML
PDF page 626
DOSAGE AND ROUTES • Adult: PO 120 mg daily for a minimum of 6 mo Qtc Interval increase: Interval >500 msec, stop treatment, when Qtc decreases to 30 msec (of baseline or ≤480 msec), restart at 80 mg/day Available form: Tablet 40 mg
PDF page 626
• Adult: PO 120 mg daily for a minimum of 6 mo Qtc Interval increase: Interval >500 msec, stop treatment, when Qtc decreases to 30 msec (of baseline or ≤480 msec), restart at 80 mg/day Available form: Tablet 40 mg
PDF page 626